Chintu Patel insider trades

Open-market stock purchases and sales by Chintu Patel, Co-CEO at Amneal Pharmaceuticals, Inc, from SEC Form 4 filings since May 7, 2018.

Recent trades

DateStockTradeValue
Aug 10, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—
Mar 4, 2026AMRX Amneal Pharmaceuticals, IncSold (not open market)$385K
Mar 4, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—
Mar 3, 2026AMRX Amneal Pharmaceuticals, IncSold (not open market)$4.2M
Mar 3, 2026AMRX Amneal Pharmaceuticals, IncSold (not open market)$228K
Mar 3, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—
Mar 3, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—
Mar 2, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—
Mar 2, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—
Mar 2, 2026AMRX Amneal Pharmaceuticals, IncBought (not open market)—

Companies traded

  • AMRX Amneal Pharmaceuticals, Inc: 6 buys, last Aug 10, 2026

Get free alerts when Chintu Patel files a new trade →